Dr. Mayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Dana Farber Cancer Institute, D-1608
Boston, MA 02215Phone+1 617-632-3474Fax+1 617-632-2260- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1969 - 1971
Harvard Medical SchoolClass of 1969
Certifications & Licensure
NY State Medical License 1970 - Present
MA State Medical License 1974 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
- Super Doctor SuperDoctors.com
Clinical Trials
- SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed Start of enrollment: 1994 Mar 01
- S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed Start of enrollment: 1994 Dec 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.Battaglin, F., Ou, F., Qu, X., Niedzwiecki, D., Zemla, T., Blanke, C., Kabbarah, O., Innocenti, F., Hochster, H., Goldberg, R., Mayer, R., Ashouri, K., Venook, A., Len...> ;Journal of Clinical Oncology. 2024 Mar 8
- Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.Huffman, B., Singh, H., Ali, L., Horick, N., Wang, S., Hoffman, M., Metayer, K., Murray, S., Bird, A., Abrams, T., Biller, L., Chan, J., Meyerhardt, J., McCleary, N., ...> ;Journal for Immunotherapy of Cancer. 2024 Jan 25
- Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-...Cohen, R., Raeisi, M., Chibaudel, B., Yoshino, T., Shi, Q., Zalcberg, J., Adams, R., Cremolini, C., Grothey, A., Mayer, R., Van Cutsem, E., Tabernero, J., Bando, H., M...> ;European Journal of Cancer. 2024 Mar 1
- Join now to see all
Press Mentions
In Memoriam: Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber’s Adult Oncology ProgramSeptember 8th, 2022- Dan Hayes Witnessed Cancer History, Now He Is Documenting It in a PodcastJune 4th, 2021
Adjuvant FOLFIRINOX Gives Big Boost to Pancreatic Ca SurvivalDecember 19th, 2018- Join now to see all
Grant Support
- Graduate Training In Cancer ResearchNational Cancer Institute1990–2011
- Bladder Permeability Of FluoresceinNational Center For Research Resources2005
- Clinical Oncology Research Career Development ProgramNational Cancer Institute1992–1996
Professional Memberships
- Fellow
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
